Ignite Creation Date:
2025-12-26 @ 5:23 PM
Ignite Modification Date:
2026-02-06 @ 2:16 AM
Study NCT ID:
NCT04507906
Status:
COMPLETED
Last Update Posted:
2022-06-28
First Post:
2020-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC
Sponsor:
Shanghai Chest Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LS2025
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |